BioNTech SE (BNTX) highlights AI strategy and pipeline uses in AI Day

Rhea-AI Filing Summary

BioNTech SE filed a Form 6‑K to inform investors that on October 1, 2025 it hosted its second AI Day together with its artificial intelligence company InstaDeep Ltd. This event is part of BioNTech’s “Innovation Series” and provided an overview of its AI strategy, its AI capabilities, and how AI is applied across BioNTech’s product pipeline and internal processes.

The related investor presentation, offering more detail on these AI initiatives, is furnished as Exhibit 99.1 to the report.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF OCTOBER 2025

COMMISSION FILE NUMBER 001-39081

BioNTech SE
(Translation of registrant’s name into English)

An der Goldgrube 12

D-55131 Mainz

Germany

+49 6131-9084-0
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F: Form 20‑F ☒ Form 40‑F ☐

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7): ☐

DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K

On October 1, 2025, BioNTech SE (“BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd., hosted its second AI Day, an edition of BioNTech’s “Innovation Series”, providing an overview of BioNTech’s AI strategy and capabilities and the application of AI in BioNTech’s pipeline and internal processes. The presentation is attached hereto as Exhibit 99.1.

SIGNATURE

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BioNTech SE

By:

/s/ Ramon Zapata-Gomez

By:

/s/ Dr. Sierk Poetting

Name: Ramon Zapata-Gomez

Name: Dr. Sierk Poetting

Title: Chief Financial Officer

Title: Chief Operating Officer

Date: October 1, 2025

EXHIBIT INDEX

Exhibit			Description of Exhibit
99.1			Presentation

FAQ

What did BioNTech SE (BNTX) report in its October 2025 Form 6-K?

BioNTech SE reported that on October 1, 2025 it held its second AI Day, part of its “Innovation Series”, highlighting its artificial intelligence strategy, capabilities, and how AI is used in its pipeline and internal processes.

What is the focus of BioNTech SE’s AI Day mentioned in the Form 6-K?

The AI Day focused on providing an overview of BioNTech SE’s AI strategy, its AI capabilities, and the application of artificial intelligence in both its development pipeline and internal processes.

Who partnered with BioNTech SE for the second AI Day described in the Form 6-K?

BioNTech SE hosted the second AI Day alongside InstaDeep Ltd., its artificial intelligence company.

What additional material is included with BioNTech SE’s October 2025 Form 6-K?

The Form 6-K includes as Exhibit 99.1 a presentation that provides further detail on BioNTech SE’s AI strategy, capabilities, and applications.

Does the BioNTech SE Form 6-K include financial or earnings data?

The Form 6-K excerpt describes an AI Day event and references a presentation; it centers on strategy and capabilities rather than financial or earnings data.

Which executives signed BioNTech SE’s October 2025 Form 6-K?

The report was signed on behalf of BioNTech SE by Chief Financial Officer Ramon Zapata-Gomez and Chief Operating Officer Dr. Sierk Poetting.